Favorable response to pemetrexed, cisplatin and bevacizumab in invasive mucinous adenocarcinoma: A case report and literature review.

Sun, Xian Wen; Ding, Yong Jie; Zhang, Yu Yan; Chen, Pei Li; Yan, Ya Ru; Shen, Ji Min; Li, Qing Yun

Sun, Xian Wen; Ding, Yong Jie; Zhang, Yu Yan; Chen, Pei Li; Yan, Ya Ru; Shen, Ji Min; Li, Qing Yun.

Afiliación

Sun XW; Department of Respiratory Medicine and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China.
Ding YJ; Department of Respiratory Medicine and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China.
Zhang YY; Department of Respiratory Medicine and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China.
Chen PL; Department of Respiratory Medicine, Zhongwei People's Hospital, Ningxia Hui Autonomous Region 751700, P.R. China.
Yan YR; Department of Respiratory Medicine and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China.
Shen JM; Department of Respiratory Medicine and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China.
Li QY; Department of Respiratory Medicine and Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, P.R. China.

Mol Clin Oncol ; 9(2): 192-196, 2018 Aug.

Article en En | MEDLINE | ID: mdl-30101020

Palabras clave

bevacizumab; chemotherapy; cisplatin; invasive mucinous adenocarcinoma; pemetrexed

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Clin Oncol Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google